Loading…
Reported covered position: Chief of Staff for former Congresswoman Carolyn McCarthy (D-NY) and Deputy Chief of Staff for Congressman Ed Perlmutter (D-CO)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patients’ Right to Know Their Medication Act of 2023
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.
Patients’ Right to Know Their Medication Act of 2023
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HEALTHCARE SUPPLY CHAIN ASSOCIATION (HSCA) via VENN STRATEGIES
2026 · third_quarter · Q3
Issues related to Group Purchasing Organizations
Issues related to Group Purchasing Organizations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| UCB, INC. |
| 23 |
| 2021–2026 |
| THE PERSONAL CARE PRODUCTS COUNCIL | 11 | 2024–2026 |
| AVANIR PHARMACEUTICALS, INC. | 10 | 2021–2022 |
| FUTURE OF PHARMACY COALITION | 8 | 2021–2022 |
| MAGNUS MEDICAL INC. | 8 | 2024–2025 |
| TRINETX | 8 | 2019–2020 |
| 7-ELEVEN | 7 | 2023–2024 |
| AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS | 4 | 2021 |
| BIOMARIN PHARMACEUTICAL INC. | 4 | 2016–2017 |
| CALA HEALTH | 4 | 2023–2024 |
| EMPLOYEE-OWNED S CORPORATIONS OF AMERICA | 4 | 2017–2025 |
| HEALTHCARE SUPPLY CHAIN ASSOCIATION | 3 | 2026 |
| BRAINFUTURES | 2 | 2024 |
| THE HARTFORD | 1 | 2026 |
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and H.R. 1503, and FDA's proposed PMI rule.
Patients’ Right to Know Their Medication Act of 2023
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.
Patients’ Right to Know Their Medication Act of 2023
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.
Prescription Information Modernization Act of 2023
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and H.R. 1503, and FDA's proposed PMI rule.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Taiwan Invasion Prevention Act
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Restoring Community Input and Public Protections in Oil and Gas Leasing Act of 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2022
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 6519, the Patients' Right to Know Their Medication Act of 2022.
Patients’ Right to Know Their Medication Act of 2019
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019.
Patients’ Right to Know Their Medication Act of 2019
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019.
Patients’ Right to Know Their Medication Act of 2019
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019 and monitoring H.R. 7614 the FY21 Labor-HHS-Education Appropriations Bill.
Patients’ Right to Know Their Medication Act of 2019
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019 and monitoring H.R. 7614 the FY21 Labor-HHS-Education Appropriations Bill.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019 and monitoring H.R. 7614 the FY21 Labor-HHS-Education Appropriations Bill.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019 and monitoring H.R. 7614 the FY21 Labor-HHS-Education Appropriations Bill.
National Defense Authorization Act for Fiscal Year 2020
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promotion of legislative language within H.R. 2500, the National Defense Authorization Act of 2020, to ensure that prescription drugs made available to Department of Defense military treatment facilities include labels that are printed and physically accompany the package from which the drug is to be dispensed and such label provides adequate directions for use of such drug.
National Defense Authorization Act for Fiscal Year 2020
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promotion of legislative language within H.R. 2500, the National Defense Authorization Act of 2020, to ensure that prescription drugs made available to Department of Defense military treatment facilities include labels that are printed and physically accompany the package from which the drug is to be dispensed and such label provides adequate directions for use of such drug.
Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2020, and for other purposes.
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promotion of legislative language within H.R. 3164, the agriculture, Rural Development, Food and Drug Administration, and Related agencies appropriations Act, 2020, to eliminate funding to complete regulations that would create an e-labeling standard for pharmaceutical packaging information.
Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2020, and for other purposes.
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promotion of legislative language within H.R. 3164, the agriculture, Rural Development, Food and Drug Administration, and Related agencies appropriations Act, 2020, to eliminate funding to complete regulations that would create an e-labeling standard for pharmaceutical packaging information.
Making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2020, and for other purposes.
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promotion of legislative language within H.R. 3164, the agriculture, Rural Development, Food and Drug Administration, and Related agencies appropriations Act, 2020, to eliminate funding to complete regulations that would create an e-labeling standard for pharmaceutical packaging information.
Patients’ Right to Know Their Medication Act of 2019
Client: PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION · Firm: VENN STRATEGIES
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 5198, Patients' Right to Know Their Medication Act of 2019.
2026 · second_quarter · Q2
Issues related to Group Purchasing Organizations
Issues related to Group Purchasing Organizations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE SUPPLY CHAIN ASSOCIATION (HSCA) via VENN STRATEGIES
2026 · first_quarter · Q1
Issues related to Group Purchasing Organizations
Issues related to Group Purchasing Organizations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Q3
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2026 · third_quarter · Q3
Issues related to personal care products, Humane Cosmetics Act, and issues related to sunscreen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2026 · third_quarter · Q3
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2026 · third_quarter · Q3
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2026 · third_quarter · Q3
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2026 · third_quarter · Q3
General Healthcare issues, including drug accessibility, importation and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2026 · second_quarter · Q2
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2026 · second_quarter · Q2
Issues related to personal care products, Humane Cosmetics Act, and issues related to sunscreen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2026 · second_quarter · Q2
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2026 · second_quarter · Q2
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2026 · second_quarter · Q2
General Healthcare issues, including drug accessibility, importation and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE HARTFORD via VENN STRATEGIES
2026 · second_quarter · RR
salient financial services, insurance, artificial intelligence, health care, supplemental benefits, autonomous vehicle and automobile related issues, third-party litigation, and other topics as requested
salient financial services, insurance, artificial intelligence, health care, supplemental benefits, autonomous vehicle and automobile related issues, third-party litigation, and other topics as requested
salient financial services, insurance, artificial intelligence, health care, supplemental benefits, autonomous vehicle and automobile related issues, third-party litigation, and other topics as requested
2026 · first_quarter · Q1
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2026 · first_quarter · Q1
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2026 · first_quarter · Q1
Issues related to personal care products, Humane Cosmetics Act, and issues related to sunscreen.
Issues related to personal care products, Humane Cosmetics Act, and issues related to sunscreen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2026 · first_quarter · Q1
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2026 · first_quarter · Q1
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2026 · first_quarter · Q1
General Healthcare issues, including drug accessibility, importation and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAGNUS MEDICAL INC. via VENN STRATEGIES
2025 · fourth_quarter · 4T
Issues related to reimbursement rates for medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2025 · fourth_quarter · Q4
Issues related to personal care products, including the Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act, Humane Cosmetics Act, and OMUFA.
Issues related to personal care products, including the Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act, Humane Cosmetics Act, and OMUFA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2025 · fourth_quarter · Q4
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2025 · fourth_quarter · Q4
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAGNUS MEDICAL INC. via VENN STRATEGIES
2025 · fourth_quarter · Q4
Issues related to reimbursement rates for medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2025 · fourth_quarter · Q4
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2025 · fourth_quarter · Q4
General Healthcare issues, including drug accessibility, importation and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Q3
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2025 · third_quarter · Q3
Issues related to personal care products, including the Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act, Humane Cosmetics Act, and OMUFA.
Issues related to personal care products, including the Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act, Humane Cosmetics Act, and OMUFA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2025 · third_quarter · Q3
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAGNUS MEDICAL INC. via VENN STRATEGIES
2025 · third_quarter · Q3
Issues related to reimbursement rates for medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2025 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
EMORY UNIVERSITY via VENN STRATEGIES
2025 · third_quarter · Q3
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2025 · third_quarter · Q3
General Healthcare issues, including drug accessibility, importation and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2025 · third_quarter · Q3
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAGNUS MEDICAL INC. via VENN STRATEGIES
2025 · third_quarter · RA
Requesting CMS to maintain current APC assignments for SAINT services
Requesting CMS to maintain current APC assignments for SAINT services
2025 · second_quarter · Q2
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2025 · second_quarter · Q2
Issues related to personal care products, including the Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act, Humane Cosmetics Act, and OMUFA.
Issues related to personal care products, including the Supporting Accessible, Flexible, and Effective (SAFE) Sunscreen Standards Act, Humane Cosmetics Act, and OMUFA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2025 · second_quarter · Q2
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2025 · second_quarter · Q2
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2025 · second_quarter · Q2
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2025 · second_quarter · Q2
General Healthcare issues, including drug accessibility, importation and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Q1
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2025 · first_quarter · Q1
Issues related to personal care products, including sunscreen.
Issues related to personal care products, including sunscreen.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2025 · first_quarter · Q1
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Promoting continued access to pharmaceutical printed packaging information, including promotion for the Patients' Right to Know Their Medication Act, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2025 · first_quarter · Q1
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2025 · first_quarter · Q1
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2025 · first_quarter · Q1
General Healthcare issues, including drug accessibility, importation and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Q4
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2024 · fourth_quarter · Q4
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2024 · fourth_quarter · Q4
Issues related to personal care products.
Issues related to personal care products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2024 · fourth_quarter · Q4
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAGNUS MEDICAL INC. via VENN STRATEGIES
2024 · fourth_quarter · 4T
Issues related to Medicare coverage of innovative medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2024 · fourth_quarter · Q4
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2024 · fourth_quarter · Q4
General Healthcare issues, including drug accessibility, importation and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Q3
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2024 · third_quarter · Q3
Issues related to personal care products, including but not limited to sunscreen and the humane cosmetic acts.
Issues related to personal care products, including but not limited to sunscreen and the humane cosmetic acts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2024 · third_quarter · Q3
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.
Educating offices about paper labeling in FDA appropriations.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2024 · third_quarter · Q3
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAGNUS MEDICAL INC. via VENN STRATEGIES
2024 · third_quarter · Q3
Issues related to Medicare coverage of innovative medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMPLOYEE-OWNED S CORPORATIONS OF AMERICA via VENN STRATEGIES
2024 · third_quarter · Q3
Legislation and other proposed policy change impacting S Corporation ESOPs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
EMORY UNIVERSITY via VENN STRATEGIES
2024 · third_quarter · Q3
Infrastructure needs related to undergraduate and graduate education.
Health equity.
Policy issues related to hospitals.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2024 · third_quarter · Q3
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation, and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · 3T
Issues relating to the Farm Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Q3
Issues relating to the Farm Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Q2
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2024 · second_quarter · Q2
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and FDA's proposed PMI rule.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2024 · second_quarter · Q2
Issues related to personal care products, including but not limited to sunscreen and the humane cosmetic acts.
Issues related to personal care products, including but not limited to sunscreen and the humane cosmetic acts.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2024 · second_quarter · Q2
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MAGNUS MEDICAL INC. via VENN STRATEGIES
2024 · second_quarter · Q2
Issues related to Medicare coverage of innovative medical devices
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2024 · second_quarter · Q2
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Health equity.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2024 · second_quarter · Q2
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation, and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via VENN STRATEGIES
2024 · second_quarter · 2T
Advocating for innovative therapies to treat mental health and substance abuse disorder.
Advocating for innovative therapies to treat mental health and substance abuse disorder.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · second_quarter · Q2
Issues relating to the Farm Bill.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Q1
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2024 · first_quarter · Q1
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2023, and H.R. 1503, and FDA's proposed PMI rule.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2024 · first_quarter · Q1
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2024 · first_quarter · Q1
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Health equity.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2024 · first_quarter · Q1
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation, and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALA HEALTH via VENN STRATEGIES
2024 · first_quarter · 1T
Requesting greater access to product and support to ensure Medicare consideration prior to finalizing coverage.
Requesting greater access to product and support to ensure Medicare consideration prior to finalizing coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALA HEALTH via VENN STRATEGIES
2024 · first_quarter · Q1
Optimizing patient access through Medicare coverage.
Optimizing patient access through Medicare coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRAINFUTURES via VENN STRATEGIES
2024 · first_quarter · Q1
Advocating for innovative therapies to treat mental health and substance abuse disorder.
Advocating for innovative therapies to treat mental health and substance abuse disorder.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Q1
Issues relating to the Farm Bill, including the Supplemental Nutrition Assistance Program (SNAP).
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE, Transportation, Dept of (DOT)
MAGNUS MEDICAL INC. via VENN STRATEGIES
2024 · second_quarter · RR
Work to finalize the New Technology APC
THE PERSONAL CARE PRODUCTS COUNCIL via VENN STRATEGIES
2024 · second_quarter · RR
Lobbying for interests related to personal care products, including but not limited to the humane cosmetic acts.
Lobbying for interests related to personal care products, including but not limited to the humane cosmetic acts.
2023 · fourth_quarter · Q4
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · fourth_quarter · Q4
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Educating offices about paper labeling in FDA appropriations.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PACIRA PHARMACEUTICALS INC. via VENN STRATEGIES
2023 · fourth_quarter · Q4
Improving access to non-opioid approaches to pain management.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2023 · fourth_quarter · Q4
Infrastructure needs related to undergraduate and graduate education.
Policy issues related to hospitals.
Health equity.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ELI LILLY AND COMPANY via VENN STRATEGIES
2023 · fourth_quarter · Q4
Proposals on patent policy impacting biopharmaceutical innovation.
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation, and innovation policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CALA HEALTH via VENN STRATEGIES
2023 · fourth_quarter · Q4
Requesting greater access to product and support to ensure Medicare consideration prior to finalizing coverage.
Requesting greater access to product and support to ensure Medicare consideration prior to finalizing coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Q4
Electric vehicle charging.
Filing targets: Energy, Dept of, Transportation, Dept of (DOT)
CALA HEALTH via VENN STRATEGIES
2023 · fourth_quarter · RR
Requesting greater access to product and support to ensure Medicare consideration prior to finalizing coverage.
Requesting greater access to product and support to ensure Medicare consideration prior to finalizing coverage.
Requesting greater access to product and support to ensure Medicare consideration prior to finalizing coverage.
2023 · third_quarter · Q3
Electric vehicle charging.
Filing targets: Energy, Dept of
2023 · third_quarter · Q3
Policies related to biopharmaceutical access and innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EMORY UNIVERSITY via VENN STRATEGIES
2023 · third_quarter · Q3
Policy issues related to hospitals.
Health equity.
Infrastructure needs related to undergraduate and graduate education.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION via VENN STRATEGIES
2023 · third_quarter · Q3
Educating offices about paper labeling in FDA appropriations.
Promoting continued access to pharmaceutical printed packaging information, including promotion for H.R. 1173, the Patients' Right to Know Their Medication Act of 2022, and H.R. 1503, and FDA's proposed PMI rule.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
salient financial services, insurance, artificial intelligence, health care, supplemental benefits, autonomous vehicle and automobile related issues, third-party litigation, and other topics as requested